The March/April 2008 issue of Australian Life Scientist is out now - and it's free. [ + ]

US researchers studying a protein involved in T cell development find it promotes breast cancer growth and spread. [ + ]

Cytopia goes into Phase II trials for vascular disrupting agent while Benitec licensee agrees to develop RNAi-based therapy for hepatitis C. [ + ]

Royal jelly kick-starts DNA methylation in bees, ANU researchers find. [ + ]

Canadian bioinformaticians develop new tools to create 3D structure of RNA. [ + ]

Progen goes into Phase III and ChemGenex Phase II, Bionomics looks at anxiety, Clinuvel gets orphan designation and Avexa announces collaboration and good results. [ + ]

Planetary scientist asks the question: should we expect extraterrestrials to be as stupid as we are? [ + ]

Thermo Fisher Scientific has opened a state-of-the-art facility in Adelaide, SA.

Turkish researchers have conducted a small clinical trial of breast cancer drug tamoxifen in people with bipolar disorder. [ + ]

Blood platelet protein regulates serotonin transporter and determines blood serotonin levels. [ + ]

C. elegans caps its chromosomes with a G-tail off the right and a C-tail off the left. [ + ]

Two papers by WAIMR scientists unlock how genes and hormones contribute to red blood cell formation. [ + ]

UQ researchers are developing a predictive test for type 1 diabetes by tracing activation of the NF-kappa B pathway. [ + ]

What's New in LAB Technology editor Janette Woodhouse reports on the Australian contingent at Pittcon 2008.

Elizabeth Blackburn accepts her L'Oreal women in science award in Paris. [ + ]